Also categorized in BoardMoves:
Honest Company Diversifies Its Leadership With A Second Female Board Member
x hide permanently

Mesa Labs Announces Changes in The Composition of Its Board of Directors

GlobeNewswire

Jennifer Alltoft About the Directors David is due to retire from his current position as CEO of Terumo BCT on April 1, 2019. In his nearly 20 years at the helm of Terumo BCT, the company grew annual revenues almost six-fold, to nearly $1 billion and he guided the company through multiple changes in name and ownership. Jenny joins after a 32-year career at Pfizer, Inc., where she held multiple positions in Research and Development, Sales & Marketing, Technical Support and General Management...

Mentions: Management CFO AMP